These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19232278)

  • 41. [Eosinophilic esophagitis: new standards in diagnosis and therapy of chronic retrosternal pain].
    Engel MA; Raithel M; Hahn EG; Konturek PC
    Dtsch Med Wochenschr; 2008 May; 133(18):966-71. PubMed ID: 18431707
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of Patients With Functional Heartburn.
    Lee YY; Wu JCY
    Gastroenterology; 2018 Jun; 154(8):2018-2021.e1. PubMed ID: 29730025
    [No Abstract]   [Full Text] [Related]  

  • 43. The nonerosive reflux disease-gastroesophageal reflux disease controversy.
    Winter JW; Heading RC
    Curr Opin Gastroenterol; 2008 Jul; 24(4):509-15. PubMed ID: 18622168
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy.
    Bredenoord AJ; Weusten BL; Timmer R; Conchillo JM; Smout AJ
    Am J Gastroenterol; 2006 Mar; 101(3):453-9. PubMed ID: 16464226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictors of response to proton pump inhibitor therapy among children with significant esophageal eosinophilia.
    Dranove JE; Horn DS; Davis MA; Kernek KM; Gupta SK
    J Pediatr; 2009 Jan; 154(1):96-100. PubMed ID: 18783791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effect of antianxiety and anti-depressive agents for the acid-related gastrointestinal diseases].
    Oshima T; Miwa H
    Nihon Rinsho; 2015 Jul; 73(7):1185-9. PubMed ID: 26165078
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonerosive reflux disease.
    Waring JP
    Semin Gastrointest Dis; 2001 Jan; 12(1):33-7. PubMed ID: 11215854
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Responsiveness of measures of heartburn improvement in non-erosive reflux disease.
    Junghard O; Halling K
    Health Qual Life Outcomes; 2007 Jun; 5():32. PubMed ID: 17562006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proton pump inhibitor failure--what are the therapeutic options?
    Fass R
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S33-8. PubMed ID: 19262545
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: normalization by treatment with a proton pump inhibitor.
    Mine S; Iida T; Tabata T; Okada Y; Tanaka Y
    J Gastroenterol Hepatol; 2008 Feb; 23(2):303-9. PubMed ID: 17725600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
    Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
    Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease.
    Lee ES; Kim N; Lee SH; Park YS; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
    Aliment Pharmacol Ther; 2009 Jul; 30(2):154-64. PubMed ID: 19392871
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy.
    Savarino E; Zentilin P; Tutuian R; Pohl D; Casa DD; Frazzoni M; Cestari R; Savarino V
    Am J Gastroenterol; 2008 Nov; 103(11):2685-93. PubMed ID: 18775017
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The role of esophageal manometry in the management of the patients with gastro-esophageal reflux disease and Barrett's esophagus].
    Hoară P; Bîrlă R; Gîndea C; Constantin A; Panaitescu G; Iordan N; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(4):407-12. PubMed ID: 18780613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Short- and long-term management of heartburn and other acid-related disorders: development of an algorithm for primary care providers.
    Fennerty MB; Finke KB; Kushner PR; Peura DA; Record L; Riley L; Ruoff GE; Simonson W; Wright WL
    J Fam Pract; 2009 Jul; 58(7 Suppl Short):S1-12. PubMed ID: 19825313
    [No Abstract]   [Full Text] [Related]  

  • 56. [Diagnosis and treatment of gastroesophageal reflux in the adult: guidelines recommended by French and Belgian consensus].
    Henry JP; Lenaerts A; Ligny G
    Rev Med Brux; 2001 Feb; 22(1):27-32. PubMed ID: 11252902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proton pump inhibitor influence on reflux in Barrett's oesophagus.
    Smythe A; Troy GP; Ackroyd R; Bird NC
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):881-7. PubMed ID: 18794602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia.
    Johnstone J; Nerenberg K; Loeb M
    Aliment Pharmacol Ther; 2010 Jun; 31(11):1165-77. PubMed ID: 20222914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of proton pump inhibitors in the treatment of heartburn during pregnancy.
    Christopher L
    J Am Acad Nurse Pract; 2005 Jan; 17(1):4-8. PubMed ID: 15679877
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heartburn medication side effects: should you worry? Proton pump inhibitors (PPIs) are safe for most people, but also have potential risks you should know about.
    Harv Mens Health Watch; 2013 Feb; 17(7):4. PubMed ID: 27024475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.